Moreover, epigenetic alterations in Keap1, such as Keap1/Cul3 hypermethylations, are responsible for the accumulation and aberrant activation of Nrf2 in lung [45], prostate [46], head and neck [47], colorectal [48], and ovarian cancer [49]. This evidence concerns the gene KEAP1 and ovarian cancer.